MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    www.PregSpark.com, introducing the International PregnancieS and Parkinson’s Registry

    A. Oosterbaan, M. Kapelle, H. Bogers, L. Vos, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

    Objective: To introduce the International PregnancieS and Parkinson’s Registry (www.PregSpark.com). Background: Pregnancy in Parkinson’s disease (PD) is rare, but with PD being the fastest growing…
  • 2024 International Congress

    Effects of Osteopathic Manipulative Treatment (OMT) on Lower Extremity Muscle Characteristics in Parkinson’s Disease (PD) Patients

    R. Radigan, A. Finkelstein, M. Mehra, P. Bhushan, T. Lombardo, S. Yao (Old Westbury, USA)

    Objective: To define the mechanism of Osteopathic Manipulative Treatment (OMT) in decreasing symptomology and improving gait in Parkinson’s Disease (PD) patients. Background: A key symptom…
  • 2024 International Congress

    Selective subthalamic DBS improved non-motor disorders without affecting weight gain in parkinsonism

    H. Tibar, K A. Charles, F. Naudet, PH. De-Deurwaerdère, A. Benazzouz (Rabat, Morocco)

    Objective: Evaluate the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on weight gain in Parkinsonian rats: The primary objective would be to determine whether…
  • 2024 International Congress

    Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis

    N. Xia, J. Ripping, R. Bakshi, E. Macklin, S. Molsberry, X. Chen, A. Ascherio, M. Schwarzschild (Charlestown, USA)

    Objective: To explore piperine as a potential biomarker for Parkinson’s disease (PD) among GBA and LRRK2 mutation carriers and non-carriers. Background: Piperine is a yellow…
  • 2024 International Congress

    Nigral Neuroinflammation and Dopaminergic Neurons in PD, MSA and PSP: A Comparative Clinicopathological Study

    E. Backman, M. Gardberg, L. Luntamo, M. Peurla, T. Vahlberg, P. Borghammer, N. Stefanova, G. Wenning, V. Kaasinen (Turku, Finland)

    Objective: To investigate nigral neuroinflammatory markers and dopaminergic neuron counts in parkinsonian disorders, comparing their profiles across conditions. Background: In degenerative parkinsonian disorders, the primary…
  • 2024 International Congress

    Utilization of Skin Punch Biopsy for the Diagnosis of Alpha-synucleinopathy in Clinical Practice

    C. Gummerson, S. Tinaz, V. Santini, A. Zubair (New Haven, USA)

    Objective: To understand the use of skin punch biopsies for diagnosis and management of α-synucleinopathy within a large medical system. Background: Skin punch biopsy has…
  • 2024 International Congress

    Prediction of Time-to-Phenoconversion to Parkinsonism in Idiopathic REM Sleep Behavior Disorder (iRBD)

    SM. Fereshtehnejad, A. Delva, Y. Zeighami, M. Dadar, A. Pelletier, J. Montplaisir, JF. Gagnon, C. Marras, R. Postuma (Toronto, Canada)

    Objective: To develop a tool for the prediction of time-to-phenoconversion in individuals with iRBD during the prodromal stage of parkinsonism. Background: Parkinson’s disease(PD) and dementia…
  • 2024 International Congress

    The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.

    S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The purpose of this study is to investigate the difficulties faced by very late-onset patients with Parkinson’s disease (PD), caregivers and attending physicians, and…
  • 2024 International Congress

    The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease

    J. Parmera, P. Cullinane, S. Wrigley, T. Revesz, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

    Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…
  • 2024 International Congress

    Detecting Mild Cognitive Impairment in Parkinson’s Disease using Speech Markers

    K. Smith, J. Williamson, T. Quatieri (Worcester, USA)

    Objective: To identify speech acoustic measures associated with mild cognitive impairment in PD (PD-MCI). Background: Detection of PD-MCI is a challenge for clinical care and…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley